References
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr., Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr., Stone NJ (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227–239
LaRosa JC (2007) Low-density lipoprotein cholesterol reduction: the end is more important than the means. Am J Cardiol 100:240–242
Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL (2007) Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin 23:2009–2026
Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K (2002) Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 106:1943–1948
Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E (2008) Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358:1431–43
Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78:965–78
Visser MN, Trip MD, Pritchard PH, Tam P, Lukic T, et al. (2008) Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia. Eur J Clin Pharmacol. Epub March 5
Lütjohann D, Bjorkhem I, Beil UF, von Bergmann K (1995) Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res 36:1763–1773
Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE (2000) Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 41:697–705
Hallikainen MA, Sarkkinen ES, Gylling H, Erkkila AT, Uusitupa MI (2000) Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 54:715–725
Gylling H, Puska P, Vartiainen E, Miettinen TA (1999) Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. J Lipid Res 40:593–600
Wasan KM, Peteherych KD, Najafi S, Zamfir C, Pritchard PH (2001) Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats. J Pharm Pharm Sci 4:207–216
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
von Bergmann, K. Disodium ascorbyl phytostanol phosphate. A new cholesterol-lowering drug?. Eur J Clin Pharmacol 64, 649–650 (2008). https://doi.org/10.1007/s00228-008-0491-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0491-9